Aileron Therapeutics (ALRN) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.86
-0.62
-0.38
-0.14

Details

Expected EPS
-0.245
Actual EPS
-0.27
Surprise EPS
-0.03
Surprise Percent
+10.2%

Description

Aileron Therapeutics (ALRN) has reported earnings of -0.27 per share for Q4 2024.

0 Comments

Share your thoughts